OTTAWA—The Canadian government has characterized the proposed trade agreement between Canada and the European Union (CETA) as its top trade priority. The deal would increase trade by removing tariffs from many products, but also create significant costs. For example, an extension of patent protections for pharmaceutical drugs could raise health-care costs by millions of dollars, while new protections for hundreds of geographical indications may restrict Canadian producers of common cheeses, wines, and meats.
Enter your email address to
register a free account.